We are monitoring the impact of COVID-19 on Asia Pacific Early Toxicity Testing Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 5740
Share on
Share on

Asia Pacific Early Toxicity Testing Market Research Report - Segmented By Technique, Assays, End-user & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Size, Share, Growth, Trends and Forecast | 2019 - 2024

Pulished: August, 2019
ID: 5740
Pages: 145

Asia Pacific Early Toxicity Testing Market Size & Growth (2019 – 2024):

The Size of the Early Toxicity Testing Market in the Asia Pacific is expected to reach USD 158.51 million by 2024, increasing at a CAGR of 8.4% during the forecast period 2019-2024.

Toxicity is an extent to which a chemical substance or a particular mixture of substances can damage a living organism. During the drug development of the diseases, it has been observed that nearly 28% of the drugs are failing in the later stages of the development causing huge financial losses in the pharmaceutical, food and other industries. So, to avoid this situation, early toxicity testing is implemented in which different types of toxic tests are conducted to remove the toxic substance in the early stages reducing the risk of late-stage failure.

Some of the toxicity tests include carcinogenicity, acute toxicity tests, systemic toxicity, neurotoxicity, and others. All these tests are performed in in-vivo, in-vitro or in-silico techniques. In-vivo toxicity testing is done on the living animals whereas in-vitro technique testing is performed in the laboratories using biochemical assays. In-silico technique testing includes the data analysis on the computer with the help of data mining and modeling tools. These toxicity tests can easily prove to the regulatory bodies that they are extremely safe to human health without causing any adverse effects in the future.

The primary factor driving the Asia-Pacific early toxicity testing market is early toxicity tests that helps the decrease the risk of drug failure in the later stages of the disease. Other factors include increased investment in the R&D of toxic tests to develop new cell assays methods, growing awareness of the regulatory authorities, rise in the demand for early toxicity testing, technology advancements in biotechnology and the favorable government funding in the biotech sector. However, side-effects like skin irritation, lack of awareness about toxicity and stringent government rules will hamper the market growth.

Asia Pacific Early Toxicity Testing Market has been segmented and sub-segmented into the following categories

  • By Technique: In-vitro, In-vivo, And In-Silico.
  • By Assays: Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Culture Assays, Other Assays.
  • By End-user: Pharmaceutical, Food And Beverages, Chemical Global Industry, Diagnostics, Cosmetics, Others.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

On the basis of region, the Asia-Pacific is expected to have the highest CAGR in the coming years owing to the rise in disposable income and growing demographics.

Top Companies dominating the Asia Pacific Early Toxicity Testing Market Profiled in the Report are Covance, Thermo Fisher Scientific, Quest Diagnostics Corporation, Agilent Technologies, Sigma Aldrich, BD Biosciences, Bio-Rad, Gene Logic, Accelrys and Charles River Laboratories. 

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Technique                   

       5.1.1 Introduction           

       5.1.2 In-vitro     

       5.1.3 In-vivo      

       5.1.4 In-Silico     

       5.1.5  Y-o-Y Growth Analysis, By Technique         

       5.1.6  Market Attractiveness Analysis, By Technique       

       5.1.7  Market Share Analysis, By Technique         

                5.2 Assays 

       5.2.1 Introduction           

       5.2.2 Cell-Based ELISA and Western Blots             

       5.2.3 Enzyme Toxicity Assays     

       5.2.4 Receptor Binding Assays   

       5.2.5 Bacterial Toxicity Assays    

       5.2.6 Tissues Culture Assays       

       5.2.7 Other Assays          

       5.2.8 Y-o-Y Growth Analysis, By Assays  

       5.2.9 Market Attractiveness Analysis, By Assays

       5.2.10 Market Share Analysis, By Assays               

                5.3 End-user                      

       5.3.1 Introduction           

       5.3.2 Pharmaceutical     

       5.3.3 Food and Beverages           

       5.3.4 Chemical Industry

       5.3.5  Diagnostics             

       5.3.6 Cosmetics

       5.3.7 Others      

       5.3.8 Y-o-Y Growth Analysis, By End-user             

       5.3.9 Market Attractiveness Analysis, By End-user           

       5.3.10 Market Share Analysis, By End-user          

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Technique

                       6.1.3.3 By Assays

                       6.1.3.4 By End-user

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Technique

                       6.1.4.3 By Assays

                       6.1.4.4 By End-user

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Technique

                       6.1.5.3 By Assays

                       6.1.5.4 By End-user

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia         

                 6.7 Rest of APAC             

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 Covance                       

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Thermo Fisher Scientific                        

                8.3 Quest Diagnostics Corporation  

                8.4 Agilent Technologies     

                8.5 Sigma Aldrich    

                8.6 BD Biosciences 

                8.7 Bio-Rad                        

                8.8 Gene Logic                  

                8.9 Accelrys                       

                8.10 Charles River Laboratories                 

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Toxicity Assays, Receptor Binding Assays along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Early Toxicity Testing  Market By Technique, From 2019-2024 ( USD Million )
  2. Asia Pacific In-vitro Market By Region, From 2019-2024 ( USD Million )
  3. Asia Pacific In-vivo Market By Region, From 2019-2024 ( USD Million )
  4. Asia Pacific In-Silico Market By Region, From 2019-2024 ( USD Million )
  5. Asia Pacific Early Toxicity Testing  Market By Assays, From 2019-2024 ( USD Million )
  6. Asia Pacific Cell-Based ELISA and Western Blots Market By Region, From 2019-2024 ( USD Million )
  7. Asia Pacific Enzyme Toxicity Assays Market By Region, From 2019-2024 ( USD Million )
  8. Asia Pacific Receptor Binding Assays Market By Region, From 2019-2024 ( USD Million )
  9. Asia Pacific Bacterial Toxicity Assays Market By Region, From 2019-2024 ( USD Million )
  10. Asia Pacific Tissues Culture Assays Market By Region, From 2019-2024 ( USD Million )
  11. Asia Pacific Other Assays Market By Region, From 2019-2024 ( USD Million )
  12. Asia Pacific Early Toxicity Testing  Market By End-user, From 2019-2024 ( USD Million )
  13. Asia Pacific Pharmaceutical Market By Region, From 2019-2024 ( USD Million )
  14. Asia Pacific Food and Beverages Market By Region, From 2019-2024 ( USD Million )
  15. Asia Pacific Chemical Industry Market By Region, From 2019-2024 ( USD Million )
  16. Asia Pacific Diagnostics Market By Region, From 2019-2024 ( USD Million )
  17. Asia Pacific Cosmetics Market By Region, From 2019-2024 ( USD Million )
  18. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  19. Japan Early Toxicity Testing  Market By Technique, From 2019-2024 ( USD Million )
  20. Japan Early Toxicity Testing  Market By Assays, From 2019-2024 ( USD Million )
  21. Japan Early Toxicity Testing  Market By End-user, From 2019-2024 ( USD Million )
  22. China Early Toxicity Testing  Market By Technique, From 2019-2024 ( USD Million )
  23. China Early Toxicity Testing  Market By Assays, From 2019-2024 ( USD Million )
  24. China Early Toxicity Testing  Market By End-user, From 2019-2024 ( USD Million )
  25. India Early Toxicity Testing  Market By Technique, From 2019-2024 ( USD Million )
  26. India Early Toxicity Testing  Market By Assays, From 2019-2024 ( USD Million )
  27. India Early Toxicity Testing  Market By End-user, From 2019-2024 ( USD Million )
  28. Australia Early Toxicity Testing  Market By Technique, From 2019-2024 ( USD Million )
  29. Australia Early Toxicity Testing  Market By Assays, From 2019-2024 ( USD Million )
  30. Australia Early Toxicity Testing  Market By End-user, From 2019-2024 ( USD Million )
  31. South Korea Early Toxicity Testing  Market By Technique, From 2019-2024 ( USD Million )
  32. South Korea Early Toxicity Testing  Market By Assays, From 2019-2024 ( USD Million )
  33. South Korea Early Toxicity Testing  Market By End-user, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample